Healthcare Professionals
Protégé RX Carotid Stent
Vascular Stenting
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Healthcare Professionals
Vascular Stenting
Select the Protégé™ RX self-expanding carotid stent system, in straight or tapered models, for custom fit in carotid arteries when stenting procedures are indicated. Tantalum GPS markers enhance visibility for precise positioning and result confirmation.
The Protégé RX Carotid Stent System, when used in conjunction with the ev3 embolic protection system, is indicated for the treatment of patients at high risk for adverse events from carotid endarterectomy who require percutaneous carotid revascularization and meet the following criteria: 1. Patients with carotid artery stenosis (≥ 50% for symptomatic patients by ultrasound or angiography or ≥ 80% for asymptomatic patients by ultrasound or angiography) of the Common or Internal Carotid Artery, AND 2. Patients must have a reference vessel diameter within the range of 4.5 mm and 9.5 mm at the target lesion.
Instructions for Use
Find this technical manual in the product labeling supplied with each device or by calling technical support for cardiovascular services: +1 763-526-7890.
Reference Number | Unconstrained Stent Diameter (mm) |
Unconstrained Stent Length (mm) |
Recommended Lumen Size (mm) |
Usable Catheter Length (cm) |
Sheath Size (F) |
Guidewire Acceptance (in) |
---|---|---|---|---|---|---|
Straight | ||||||
SECX-6-20-135 | 6 | 20 | 4.5-5.5 | 135 | 6 | 0.014 |
SECX-6-30-135 | 6 | 30 | 4.5-5.5 | 135 | 6 | 0.014 |
SECX-6-40-135 | 6 | 40 | 4.5-5.5 | 135 | 6 | 0.014 |
SECX-6-60-135 | 6 | 60 | 4.5-5.5 | 135 | 6 | 0.014 |
SECX-7-20-135 | 7 | 20 | 5.5-6.5 | 135 | 6 | 0.014 |
SECX-7-30-135 | 7 | 30 | 5.5-6.5 | 135 | 6 | 0.014 |
SECX-7-40-135 | 7 | 40 | 5.5-6.5 | 135 | 6 | 0.014 |
SECX-7-60-135 | 7 | 60 | 5.5-6.5 | 135 | 6 | 0.014 |
SECX-8-20-135 | 8 | 20 | 6.5-7.5 | 135 | 6 | 0.014 |
SECX-8-30-135 | 8 | 30 | 6.5-7.5 | 135 | 6 | 0.014 |
SECX-8-40-135 | 8 | 40 | 6.5-7.5 | 135 | 6 | 0.014 |
SECX-8-60-135 | 8 | 60 | 6.5-7.5 | 135 | 6 | 0.014 |
SECX-9-20-135 | 9 | 20 | 7.5-8.5 | 135 | 6 | 0.014 |
SECX-9-30-135 | 9 | 30 | 7.5-8.5 | 135 | 6 | 0.014 |
SECX-9-40-135 | 9 | 40 | 7.5-8.5 | 135 | 6 | 0.014 |
SECX-9-60-135 | 9 | 60 | 7.5-8.5 | 135 | 6 | 0.014 |
SECX-10-20-135 | 10 | 20 | 8.5-9.5 | 135 | 6 | 0.014 |
SECX-10-30-135 | 10 | 30 | 8.5-9.5 | 135 | 6 | 0.014 |
SECX-10-40-135 | 10 | 40 | 8.5-9.5 | 135 | 6 | 0.014 |
SECX-10-60-135 | 10 | 60 | 8.5-9.5 | 135 | 6 | 0.014 |
Tapered | ||||||
SECX-8-6-30-135 | 8/6 | 30 | (6.5-7.5)-(4.5-5.5) | 135 | 6 | 0.014 |
SECX-8-6-40-135 | 8/6 | 40 | (6.5-7.5)-(4.5-5.5) | 135 | 6 | 0.014 |
SECX-10-7-30-135 | 10/7 | 30 | (8.5-9.5)-(5.5-6.5) | 135 | 6 | 0.014 |
SECX-10-7-40-135 | 10/7 | 40 | (8.5-9.5)-(5.5-6.5) | 135 | 6 | 0.014 |
* The safety and efficacy of the Protege RX carotid stent system in the carotid indication has not been demonstrated with embolic protection devices other than with the SpiderFX™ embolic protection device. The SpiderFX embolic protection device has been demonstrated to be compatible with the Protege RX carotid stent system in bench and animal testing.
The clinical data contained within this document reflects data generated using the Protege GPS™ carotid stent system but has been determined to be applicable to the Protege RX carotid stent system in bench and animal testing
† Defined as successful deployment and retrieval of distal protection device, successful stent deployment and final diameter stenosis < 50%.
See product catalog for complete, detailed product information.